Evidence map›Paper›PMID 38425896›Full record

ArticleJACS Au2024

Asymmetrical Biantennary Glycans Prepared by a Stop-and-Go Strategy Reveal Receptor Binding Evolution of Human Influenza A Viruses.

Shengzhou Ma, Lin Liu, Dirk Eggink, Sander Herfst, Ron A M Fouchier, Robert P de Vries, Geert-Jan Boons

Open access · goldAbstract read
In one paragraph

Article in JACS Au, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Loss of hemagglutination ability by H3N2 influenza A virus, subclade K.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Expedient Assembly of MultiantennaryJournal of the American Chemical Society · 2025
    Article
  14. Article
  15. Receptor Binding Specificity of a Bovine A(H5N1) Influenza Virus.bioRxiv : the preprint server for biology · 2024
    Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Shengzhou MaComplex Carbohydrate Research Center, University of Georgia, 315 Riverbend Road, Athens, Georgia 30602, United States.
Lin LiuComplex Carbohydrate Research Center, University of Georgia, 315 Riverbend Road, Athens, Georgia 30602, United States.ORCID https://orcid.org/0000-0002-0310-5946
Dirk EgginkAmsterdam UMC Location University of Amsterdam, Department of Medical Microbiology and Infection prevention, Laboratory of Applied Evolutionary Biology, 1105 AZ Amsterdam, The Netherlands.
Sander HerfstDepartment of Viroscience, Erasmus University Medical Center, 3015 CD Rotterdam, The Netherlands.
Ron A M FouchierDepartment of Viroscience, Erasmus University Medical Center, 3015 CD Rotterdam, The Netherlands.
Robert P de VriesDepartment of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands.ORCID https://orcid.org/0000-0002-1586-4464
Geert-Jan BoonsComplex Carbohydrate Research Center, University of Georgia, 315 Riverbend Road, Athens, Georgia 30602, United States.ORCID https://orcid.org/0000-0003-3111-5954
University of Georgia · USErasmus MC · NLNational Institute for Public Health and the Environment · NLUtrecht University · NL

Funding

Integrating measurements of immune escape and in vitro replication with computational models to understand and predict the antigenic evolution of seasonal A/H3N2 influenza virusesR01AI165818 · NIAID · UNIVERSITY OF CAMBRIDGE · PI Derek James Smith · 2022 to 2026
$2.6M
Automated chemo-enzymatic synthesis of N-glycans for host-pathogen interactionsR01AI165692 · NIAID · UNIVERSITY OF GEORGIA · PI BOONS, GEERT-JAN · 2022 to 2025
$2.2M
NIAID NIH HHS R01 AI165692NIAID NIH HHS R01 AI165818
6 · The paper itself

Abstract

Glycan binding properties of respiratory viruses have been difficult to probe due to a lack of biologically relevant glycans for binding studies. Here, a stop-and-go chemoenzymatic methodology is presented that gave access to a panel of 32 asymmetrical biantennary

Identifiers

PMID38425896
PMCPMC10900492
OpenAlexW4391133779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.